MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-24-0015867
SGS Formulation Private Limited - pharma in Thiruvallur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.52 Cr
▼ 21% YoY
Net profit · FY 2025
₹9.79 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹27.63 Lakh
EBITDA margin 6.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹2.35 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
11
Provident fund records
About SGS Formulation Private Limited
Data last updated:
SGS Formulation Private Limited is a private limited company based in Thiruvallur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2016PTC113571. Its GSTIN is 33AAXCS8539A1Z0 (Tamil Nadu).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Premkumari and Saravanan Sagadevan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. S111 SIDCO Industrial Estate Kakkalur Putlur Village Thiruvallur District, Tamil Nadu, India – 631208.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.52 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹9.79 Lakh (net margin 2.2%) and EBITDA of ₹27.63 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 1% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SGS Formulation. As per MCA filings, the company has open charges of ₹2.35 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
SGS Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0015867). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sgsformulation.com.
Company Details of SGS Formulation Private Limited
CIN U74999TN2016PTC113571
Registration Number 113571
Incorporation Date 01 December 2016
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-24-0015867
Recognitions & Rankings of SGS Formulation
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. S111 SIDCO Industrial Estate Kakkalur Putlur Village Thiruvallur District, Tamil Nadu, India – 631208
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
SGS Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with SGS Formulation Private Limited
SGS Formulation operates one associated brand: SGS Formulation. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Formulation of additives and health products in the Indian industrial sector. | sgsformulation.com |
Business Activity of SGS Formulation Private Limited
The main business activity of SGS Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of SGS Formulation Private Limited FY 2025 filings available
SGS Formulation Private Limited reported revenue of ₹4.52 Cr (down 21% YoY) for FY 2025.
Revenue · FY 2025
₹4.52 Cr ▼ 21%
Net profit · FY 2025
₹9.79 Lakh margin 2.2%
EBITDA · FY 2025
₹27.63 Lakh margin 6.1%
Compounded Annual Growth Rate (CAGR) of SGS Formulation Private Limited
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 11%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 11%
5 years · compounded
▼ 2%
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of SGS Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.63 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.79 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of SGS Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SGS Formulation are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of SGS Formulation Private Limited
SGS Formulation has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Premkumari Also directs: Puduvaibazaar Private Limited | Director | 01 Dec 2016 | 9 Years 10 Months | Current |
| Saravanan Sagadevan Also directs: Shree Kumaran Industries Private Limited | Director | 01 Dec 2016 | 9 Years 10 Months | Current |
| Gnanadhas Ramesh Kumar | Director | 01 Dec 2016 | 9 Years 10 Months | Current |
Peer Comparison of SGS Formulation Private Limited
SGS Formulation Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Diosma Lifesciences Private Limited | ₹4.55 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Adroit Lifescience Private Limited | ₹4.55 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Ahmedabad, Gujarat, India |
| Baylor Pharmaceutical Private Limited | ₹4.54 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Navi Mumbai, Maharashtra, India |
| Healing Hands & Herbs Private Limited | ₹4.54 Cr (FY 2024) | •••• | •••• | 91.0% | •••• | Pune, Maharashtra, India |
| Hychem Sainor Chemicals Private Limited | ₹4.53 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| SGS Formulation Private Limited this company | ₹4.52 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Thiruvallur, Tamil Nadu, India |
| Medipaams India Private Limited | ₹4.52 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Lamet Pharma Private Limited | ₹4.52 Cr (FY 2022) | •••• | •••• | -22.0% | •••• | Thane, Maharashtra, India |
| Denizen Pharmaceuticals India Private Limited | ₹4.51 Cr (FY 2025) | •••• | •••• | 125.0% | •••• | New Delhi, Delhi, India |
| Pacific Bioengineering Private Limited | ₹4.51 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Delhi, India |
| S N D Life Science Private Limited | ₹4.5 Cr (FY 2024) | •••• | •••• | 98.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below SGS Formulation by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of SGS Formulation Private Limited
SGS Formulation Private Limited is audited by T RAGHAVENDRAN AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| T RAGHAVENDRAN AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of SGS Formulation Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of SGS Formulation Private Limited
Open charges
₹2.35 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2023 | The South Indian Bank Limited | ₹35 Lakh | Open |
| 29 Dec 2021 | Others | ₹81.02 Lakh | Open |
| 09 Mar 2018 | Indian Bank | ₹1.19 Cr | Open |
Total charge records: 3 View all charges
Legal Cases of SGS Formulation Private Limited
SGS Formulation Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thoothukudi, Tamil Nadu | Criminal miscellaneous application | Filed against the company by an individual | Pending |
| District court, Tiruvarur, Tamil Nadu | Criminal complaint | Filed against the company by State of Tamilnadu | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at SGS Formulation Private Limited
SGS Formulation Private Limited has a workforce of 11 employees as of Apr 06, 2024.
Employee count
11
Active EPFO establishments
1
Employee growth
-8.33%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on SGS Formulation Private Limited
SGS Formulation Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Gnanadhas Ramesh Kumar was appointed as Director on 01 Dec 2016.
AGM
Sgs Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sgs Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 100711498 was registered on 05 Apr 2023.
Charges
A charge with Others amounted to Rs. 81.02 Lakh with Charge ID 100556603 was registered on 29 Dec 2021.
Charges
A charge with Indian Bank of Rs. 119.04 Lakh registered on 09 Mar 2018 with Charge ID 100164609 was modified on 30 Jun 2020.
Charges
A charge with Indian Bank amounted to Rs. 119.04 Lakh with Charge ID 100164609 was registered on 09 Mar 2018.
Appointed
Gnanadhas Ramesh Kumar was appointed as Director.
Appointed
Premkumari was appointed as Director.
Appointed
Saravanan Sagadevan was appointed as Director.
Incorporation
01 Dec 2016
Sgs Formulation Private Limited was registered on 01 Dec 2016 with Roc Chennai & aged 9 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for SGS Formulation Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by SGS Formulation Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of SGS Formulation Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of SGS Formulation Private Limited
SGS Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAXCS8539A1Z0 | Tamil Nadu | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of SGS Formulation Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SGS Formulation Private Limited
SGS Formulation is an active private limited company based in Thiruvallur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2016 (10+ years old) and is registered under CIN U74999TN2016PTC113571.
SGS Formulation reported revenue of ₹4.52 Cr for FY 2025 (down 21% YoY).
SGS Formulation has 3 current directors:
- Premkumari - Director
- Saravanan Sagadevan - Director
- Gnanadhas Ramesh Kumar - Director
SGS Formulation reported a net profit of ₹9.79 Lakh (net margin 2.2%) and EBITDA of ₹27.63 Lakh (EBITDA margin 6.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of SGS Formulation is 11% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of SGS Formulation is 33AAXCS8539A1Z0, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of SGS Formulation is U74999TN2016PTC113571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SGS Formulation has 2 court cases on record: 2 filed against it. 1 is pending.
SGS Formulation was incorporated on 01 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of SGS Formulation by revenue are Diosma Lifesciences Private Limited, Adroit Lifescience Private Limited, Baylor Pharmaceutical Private Limited, Healing Hands & Herbs Private Limited, Hychem Sainor Chemicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Gnanadhas Ramesh Kumar was appointed as Director on 01 Dec 2016. Premkumari was appointed as Director on 01 Dec 2016. Saravanan Sagadevan was appointed as Director on 01 Dec 2016.